Ticker name:INSMINSMED Inc

Country: US-Sector: Healthcare, Industry: Biotechnology

terraforming in: 2025

Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation Powder, an inhaled version of the treprostinil palmitil prodrug, designed to address pulmonary arterial hypertension and various other rare lung ailments. Founded in 1988, Insmed Incorporated maintains its primary corporate offices in Bridgewater, New Jersey.

Market Cap 23B

Last close 107.02$

Key metrics

Largest 20 companies In Biotechnology

# PositionTickerCompany NameMarket CapLast PriceAction
1VRTXVERTEX PHARMACEUTICALS INC / MA122B480.5$
2REGNREGENERON PHARMACEUTICALS, INC.70B672.15$
3RVMDRevolution Medicines, Inc.38B180.39$
4ALNYALNYLAM PHARMACEUTICALS, INC.36B272.67$
5ROIVRoivant Sciences Ltd.24B34.05$
6MRNAModerna, Inc.24B59.49$
7INSMINSMED Inc23B107.02$
8INCYINCYTE CORP23B115.65$
9UTHRUNITED THERAPEUTICS Corp22B529.34$
10NBIXNEUROCRINE BIOSCIENCES INC17B173$
11BBIOBridgeBio Pharma, Inc.16B80.76$
12ASNDAscendis Pharma A/S16B251.76$
13JAZZJazz Pharmaceuticals plc15B243.47$
14EXELEXELIXIS, INC.14B55.53$
15MDGLMADRIGAL PHARMACEUTICALS, INC.12B535.69$
16BMRNBIOMARIN PHARMACEUTICAL INC11B59.11$
17AXSMAxsome Therapeutics, Inc.11B221.64$
18TECHBIO-TECHNE Corp11B71.64$
19SMMTSummit Therapeutics Inc.10B13.5$
20APGEApogee Therapeutics, Inc.10B134.15$